Any feedback?
Literature summary for 3.4.14.5 extracted from
- DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells (2006), Regul. Pept., 137, 147-155.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | use of DPPIV inhibitors could increase the risk of promoting an already existing intestinal tumour and may support the potential of colon cancer cells to metastasize | Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| HT-29 cell | - |
Homo sapiens | - |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
